Furthermore, patients with T2DM often exhibit a state of chronic low-grade inflammation, characterized by elevated levels of inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6). This evidence concerns the gene TNF and type 2 diabetes mellitus.